Abstract
We show the long‐term efficacy and safety of modified biliopancreatic diversion for the treatment of LPL ‐deficiency. How this option compares with gene therapy is difficult to evaluate due to limited experience. Surgery may be the first option in patients in whom medical therapy is ineffective and gene therapy not applicable.
Cite
CITATION STYLE
APA
Nosso, G., Capaldo, B., Cocozza, S., & Vaccaro, O. (2015). A 19 year follow‐up of a woman with lipoprotein lipase deficiency treated with biliopancreatic diversion. Clinical Case Reports, 3(12), 1030–1033. https://doi.org/10.1002/ccr3.433
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free